FDA Approves “Six Vaccines in One”

The Food and Drug Administration (FDA) has approved a new vaccine that is being billed as “six vaccines in one.” As reported by Forbes.com:

“[T]he hexavalent Vaxelis is designed to offer protection against six diseases and significantly reduce the number of shots you need to get as a little kid. Thus, to be fully immunized against diphtheria, tetanus, pertussis, hepatitis B, polio, and invasive haemophilus influenza type B disease, [children] will only have to get three doses of Vaxelis between… turning 6 weeks and turning 5 years old.”

Continue reading

FDA Approves Expanded Use of Gardasil 9 HPV Vaccine

In late 2018, the U.S. Food and Drug Administration (FDA) announced expanded approval of the Gardasil 9 human papilloma virus (HPV) vaccine. Previously approved for administration to males and females between the ages of 9 and 26, Gardasil 9 is now an approved HPV vaccine for men and women through 45 years of age.

According to the FDA’s press release:

“[The] approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range. . . . The Centers for Disease Control and Prevention has stated that HPV vaccination prior to becoming infected with the HPV types covered by the vaccine has the potential to prevent more than 90 percent of these cancers, or 31,200 cases every year, from ever developing.”

Continue reading